tiprankstipranks
Fortress Biotech (FBIO)
NASDAQ:FBIO
US Market
FBIO
Fortress Biotech
RESEARCH TOOLSreports
Want to see FBIO full AI Analyst Report?

Fortress Biotech (FBIO) Ratios

1,585 Followers

Fortress Biotech Ratios

FBIO's free cash flow for Q4 2025 was $0.66. For the 2025 fiscal year, FBIO's free cash flow was decreased by $ and operating cash flow was $-0.27. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.49 2.49 1.27 1.38 1.80
Quick Ratio
 2.30 2.30 1.06 1.26 1.69
Cash Ratio
 1.60 1.60 0.80 0.95 1.40
Solvency Ratio
 0.09 0.09 -0.28 -0.33 -0.32
Operating Cash Flow Ratio
 -1.32 -1.32 -1.12 -1.51 -1.40
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -128.31 -13.56 -17.62
Net Current Asset Value
$ 476.00K$ 476.00K$ -55.50M$ -48.92M$ -13.84M
Leverage Ratios
Debt-to-Assets Ratio
 0.40 0.40 0.53 0.53 0.43
Debt-to-Equity Ratio
 1.49 1.49 3.34 3.93 3.05
Debt-to-Capital Ratio
 0.60 0.60 0.77 0.80 0.75
Long-Term Debt-to-Capital Ratio
 0.54 0.54 0.72 0.73 0.69
Financial Leverage Ratio
 3.72 3.72 6.34 7.43 7.05
Debt Service Coverage Ratio
 -2.24 -2.24 -9.93 -6.20 -8.15
Interest Coverage Ratio
 -8.06 -8.06 -11.12 -11.37 -14.92
Debt to Market Cap
 0.80 0.58 1.39 2.88 1.76
Interest Debt Per Share
 2.98 2.98 4.13 12.47 23.80
Net Debt to EBITDA
 0.25 0.25 -0.18 -0.06 0.26
Profitability Margins
Gross Profit Margin
66.94%66.92%63.80%72.91%59.37%
EBIT Margin
-39.25%-39.24%-188.91%-167.69%-268.07%
EBITDA Margin
-31.88%-31.88%-181.17%-160.59%-255.73%
Operating Profit Margin
-111.02%-111.00%-191.38%-168.43%-268.76%
Pretax Profit Margin
-53.02%-53.01%-209.00%-181.79%-281.83%
Net Profit Margin
10.77%10.77%-79.75%-71.75%-114.30%
Continuous Operations Profit Margin
-52.04%-52.03%-209.54%-182.40%-282.42%
Net Income Per EBT
-20.32%-20.32%38.16%39.47%40.56%
EBT Per EBIT
47.76%47.76%109.21%107.93%104.86%
Return on Assets (ROA)
3.67%3.67%-31.89%-36.20%-29.42%
Return on Equity (ROE)
15.86%13.66%-202.30%-268.97%-207.51%
Return on Capital Employed (ROCE)
-51.71%-51.71%-151.57%-172.29%-122.20%
Return on Invested Capital (ROIC)
-49.97%-49.97%-145.10%-154.60%-113.59%
Return on Tangible Assets
4.31%4.31%-40.94%-41.18%-32.41%
Earnings Yield
11.00%6.67%-109.02%-248.37%-147.59%
Efficiency Ratios
Receivables Turnover
 2.11 2.11 5.54 5.49 2.67
Payables Turnover
 1.47 1.47 0.66 0.66 0.54
Inventory Turnover
 2.17 2.17 1.45 2.24 2.17
Fixed Asset Turnover
 4.27 4.27 3.37 3.60 2.29
Asset Turnover
 0.34 0.34 0.40 0.50 0.26
Working Capital Turnover Ratio
 0.91 1.36 2.26 1.25 0.44
Cash Conversion Cycle
 92.30 92.26 -234.94 -325.82 -374.40
Days of Sales Outstanding
 172.78 172.75 65.83 66.46 136.60
Days of Inventory Outstanding
 167.88 167.88 252.28 162.72 167.93
Days of Payables Outstanding
 248.37 248.37 553.05 555.00 678.93
Operating Cycle
 340.67 340.63 318.11 229.18 304.53
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.36 -2.36 -3.86 -15.81 -30.28
Free Cash Flow Per Share
 -2.36 -2.36 -4.58 -16.81 -30.79
CapEx Per Share
 0.00 0.00 0.72 1.00 0.52
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.19 1.06 1.02
Dividend Paid and CapEx Coverage Ratio
 -99.06 -99.06 -4.07 -7.60 -15.16
Capital Expenditure Coverage Ratio
 0.00 0.00 -5.35 -15.83 -58.72
Operating Cash Flow Coverage Ratio
 -0.89 -0.89 -1.06 -1.45 -1.41
Operating Cash Flow to Sales Ratio
 -1.04 -1.04 -1.39 -1.52 -2.37
Free Cash Flow Yield
-92.01%-64.41%-225.62%-558.38%-311.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 9.42 14.98 -0.92 -0.40 -0.68
Price-to-Sales (P/S) Ratio
 1.17 1.61 0.73 0.29 0.77
Price-to-Book (P/B) Ratio
 1.29 2.05 1.86 1.08 1.41
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.13 -1.55 -0.44 -0.18 -0.32
Price-to-Operating Cash Flow Ratio
 -0.98 -1.55 -0.53 -0.19 -0.33
Price-to-Earnings Growth (PEG) Ratio
 0.02 -0.15 0.01 <0.01 -0.03
Price-to-Fair Value
 1.29 2.05 1.86 1.08 1.41
Enterprise Value Multiple
 -3.42 -4.81 -0.58 -0.24 -0.04
Enterprise Value
 66.41M 97.04M 60.89M 32.08M 7.74M
EV to EBITDA
 -3.29 -4.81 -0.58 -0.24 -0.04
EV to Sales
 1.05 1.53 1.06 0.38 0.10
EV to Free Cash Flow
 -1.01 -1.48 -0.64 -0.24 -0.04
EV to Operating Cash Flow
 -1.01 -1.48 -0.76 -0.25 -0.04
Tangible Book Value Per Share
 1.24 1.24 -1.61 -2.31 3.85
Shareholders’ Equity Per Share
 1.79 1.79 1.09 2.78 7.04
Tax and Other Ratios
Effective Tax Rate
 0.02 0.02 >-0.01 >-0.01 >-0.01
Revenue Per Share
 2.27 2.27 2.77 10.42 12.78
Net Income Per Share
 0.24 0.24 -2.21 -7.48 -14.61
Tax Burden
 -0.20 -0.20 0.38 0.39 0.41
Interest Burden
 1.35 1.35 1.11 1.08 1.05
Research & Development to Revenue
 0.20 0.19 0.99 1.26 1.78
SG&A to Revenue
 1.52 1.52 1.52 0.00 0.00
Stock-Based Compensation to Revenue
 0.45 0.45 0.57 0.20 0.30
Income Quality
 2.00 2.00 0.66 0.83 0.84
Currency in USD